HEAT Trial (HER2 Antibody Therapy With Lutetium-177)

NCT06824155 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

HER2 Gene Mutation
Advanced Solid Tumors

Interventions

DRUG: 177Lu-RAD202

Sponsor

Radiopharm Theranostics, Ltd